ASTRAZENECA PLC
Business
ASTRAZENECA PLC is a global, innovation-driven biopharmaceutical company that researches, develops, manufactures and commercializes prescription medicines and vaccines. It offers a broad portfolio including small molecules, biologics, antibody‑drug conjugates, monoclonal antibodies, gene‑ and RNA‑based therapies, and vaccines across multiple therapeutic areas. Key business segments comprise Oncology; Cardiovascular, Renal & Metabolism (CVRM); Respiratory & Immunology; Vaccines & Immune Therapies; Rare Disease; and Other medicines. The company markets products and conducts R&D worldwide, distributing through direct commercial operations, partnerships and third‑party distributors across the US, Emerging Markets (including China), Europe and other regions.
Summary from filing dated 2025-02-18
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $10.23B |
| Total assets | $114.07B |
| Total liabilities | $65.36B |
| Stockholders' equity | — |
| Operating cash flow | — |